(Q41148915)

27 September 2017

title

Inhibition of human immunodeficiency virus replication by the sulfonated stilbene dye resobene (English)

1 reference

27 September 2017

Halliday SM

1

1 reference

27 September 2017

Lackman-Smith C

2

1 reference

27 September 2017

Bader JP

3

1 reference

27 September 2017

Rice WG

4

1 reference

27 September 2017

Clanton DJ

5

1 reference

27 September 2017

Zalkow LH

6

1 reference

27 September 2017

Buckheit RW Jr

7

1 reference

27 September 2017

language of work or name

1 reference

1 December 1996

1 reference

27 September 2017

1 reference

27 September 2017

volume

33

1 reference

27 September 2017

issue

1

1 reference

27 September 2017

page(s)

41-53

1 reference

Enhancement of SIV infection with soluble receptor molecules

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Sodium Pentosan Polysulfate (PPS), an Anti-HIV Agent Also Exhibits Synergism with AZT, Lymphoproliferative Activity, and Virus Enhancement

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Metabolism of nine benzidine-congener-based azo dyes in rats based on gas chromatographic assays of the urine for potentially carcinogenic metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Characterization of an HIV-1 Isolate Displaying an Apparent Absence of Virion-Associated Reverse Transcriptase Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Anti-human immunodeficiency virus effects of dextran sulfate are strain dependent and synergistic or antagonistic when dextran sulfate is given in combination with dideoxynucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Novel sulfonated and phosphonated analogs of distamycin which inhibit the replication of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Quinobene, a new potent anti-HIV agent

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Antibodies from human immunodeficiency virus-infected individuals bind to a short amino acid sequence that elicits neutralizing antibodies in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Potential anti-AIDS agents. Synthesis and antiviral activity of naphthalenesulfonic acid derivatives against HIV-1 and HIV-2

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Anti-HIV-1 and HIV-2 activity of naphthalenedisulfonic acid derivatives. Inhibition of cytopathogenesis, giant cell formation, and reverse transcriptase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alterations in the responses of their envelope glycoproteins to soluble CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

Purification of HIV-1 wild-type protease and characterization of proteolytically inactive HIV-1 protease mutants by pepstatin A affinity chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900994-1

7 January 2021

10.1016/S0166-3542(96)00994-1

Identifiers

DOI

1 reference

27 September 2017

1 reference